Alex Herrera is a Hematologist and a Hematologist Oncology expert in Duarte, CA. Herrera has been practicing medicine for over 14 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. He is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine, Oncology and licensed to treat patients in California. Herrera is currently accepting new patients.
Thomas Habermann is a Hematologist and an Oncologist in Rochester, Minnesota. Habermann has been practicing medicine for over 44 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 38 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in Minnesota. Habermann is currently accepting new patients.
James Armitage is a Hematologist and an Oncologist in Omaha, Nebraska. Armitage has been practicing medicine for over 50 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 28 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Endoscopy. He is licensed to treat patients in Nebraska. Armitage is currently accepting new patients.
Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people living with HIV in the United States. People with HIV are up to 17 times more likely to get NHL than people who do not have HIV. The disease may also be different in these two groups. More study is needed for treating people with both HIV and NHL.
Background: Burkitt lymphoma/leukemia (BL) is highly treatable, but most of the standard therapies require multiple doses of intensive chemotherapy that may require long hospital stays and frequently have severe side effects. In addition, BL is a fairly common type of cancer in patients who also have human immunodeficiency virus (HIV), but treatment outcomes are poor because standard treatments do not work ve...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.